L Chaplin

627 total citations
15 papers, 517 citations indexed

About

L Chaplin is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, L Chaplin has authored 15 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in L Chaplin's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Glycosylation and Glycoproteins Research (3 papers). L Chaplin is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Glycosylation and Glycoproteins Research (3 papers). L Chaplin collaborates with scholars based in United Kingdom and United States. L Chaplin's co-authors include Andrew Nesbitt, Mark Bodmer, J.S. Emtage, Sue Stephens, Nick D. Jones, Spencer Emtage, Mark Sopwith, D. S. Athwal, C. R. Bebbington and RB Pedley and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Biochemical Journal.

In The Last Decade

L Chaplin

15 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L Chaplin United Kingdom	11	280	238	132	79	56	15	517
Chikako Inuzuka Japan	10	248 0.9×	323 1.4×	80 0.6×	167 2.1×	32 0.6×	11	618
R. Obrist Switzerland	14	103 0.4×	138 0.6×	237 1.8×	141 1.8×	45 0.8×	47	610
R H Pang United States	10	81 0.3×	191 0.8×	201 1.5×	78 1.0×	51 0.9×	19	461
N Takami Japan	10	76 0.3×	312 1.3×	77 0.6×	60 0.8×	56 1.0×	13	535
Philip Marsh United Kingdom	12	253 0.9×	218 0.9×	266 2.0×	31 0.4×	47 0.8×	21	615
Н. В. Гнучев Russia	12	102 0.4×	269 1.1×	262 2.0×	30 0.4×	18 0.3×	50	516
Wagner R. Montor Brazil	11	168 0.6×	357 1.5×	91 0.7×	78 1.0×	57 1.0×	21	605
Sara A. Johnson United States	12	160 0.6×	296 1.2×	505 3.8×	61 0.8×	69 1.2×	18	988
Frieda Karp United States	8	92 0.3×	274 1.2×	75 0.6×	54 0.7×	46 0.8×	13	473
Xiaodi Deng United States	13	93 0.3×	339 1.4×	88 0.7×	119 1.5×	38 0.7×	22	536

Countries citing papers authored by L Chaplin

Since Specialization

Citations

This map shows the geographic impact of L Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Chaplin more than expected).

Fields of papers citing papers by L Chaplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Chaplin. The network helps show where L Chaplin may publish in the future.

Co-authorship network of co-authors of L Chaplin

This figure shows the co-authorship network connecting the top 25 collaborators of L Chaplin. A scholar is included among the top collaborators of L Chaplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Chaplin. L Chaplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Casey, Joanne L., Mark Napier, David J. King, et al.. (2002). Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study. British Journal of Cancer. 86(9). 1401–1410. 35 indexed citations

King, DJ, et al.. (1998). Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle. British Journal of Cancer. 78(10). 1307–1312. 4 indexed citations

Owens, Raymond J., Ramaswamy Ganesh, Andrew Nesbitt, et al.. (1997). The in vivo and in vitro characterisation of an engineered human antibody to E-selectin. Immunotechnology. 3(2). 107–116. 9 indexed citations

King, DJ, et al.. (1996). Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments. British Journal of Cancer. 74(9). 1397–1405. 44 indexed citations

Lewthwaite, J, Simon Blake, Tim Hardingham, et al.. (1995). Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies.. Annals of the Rheumatic Diseases. 54(5). 366–374. 21 indexed citations

Jones, Nick D., et al.. (1995). The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.. PubMed. 86(2). 319–24. 90 indexed citations

Stephens, Sue, Spencer Emtage, L Chaplin, et al.. (1995). Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses.. PubMed. 85(4). 668–74. 99 indexed citations

Suitters, Amanda, Roly Foulkes, Steven M. Opal, et al.. (1994). Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.. The Journal of Experimental Medicine. 179(3). 849–856. 52 indexed citations

Harrison, A., David Parker, Karl J. Jankowski, et al.. (1991). The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 469–476. 62 indexed citations

10.

Hubbard, Julia, et al.. (1991). Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin. Biochemical Journal. 275(3). 785–788. 32 indexed citations

11.

Chaplin, L & A. T. Andrews. (1988). Rapid preparative-scale purification of peptides derived from caseins using mass ion-exchange chromatography. Journal of Chromatography A. 450(3). 420–425. 4 indexed citations

12.

Chaplin, L, et al.. (1987). Assay of gemfibrozil in plasma by "high-performance" liquid chromatography.. Clinical Chemistry. 33(10). 1938–1938. 14 indexed citations

13.

Chaplin, L. (1986). Hydrophobic interaction fast protein liquid chromatography of milk proteins. Journal of Chromatography A. 363(2). 329–335. 27 indexed citations

14.

Chaplin, L, et al.. (1985). Reserpic acid as an inhibitor of norepinephrine transport into chromaffin vesicle ghosts.. Journal of Biological Chemistry. 260(20). 10981–10985. 21 indexed citations

15.

Mizukami, Hiroshi, et al.. (1984). Band-8 protein of human erythrocyte membrane: another Ca++ binding protein?. PubMed. 159. 47–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact